Scott Cooper
5Patents
2h-index
11Co-inventors
48Inventor score
Filing activity: Dec 9, 1992 → Jun 15, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8168600B2 | Compositions and methods for topical delivery of oligonucleotides | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6794493B2 | Antithrombin H-helix mutants | Human Necessities | 2 | Expired |
| US6143289A | Compositions of myeloid-cell-suppressive chemokines | Chemistry; Metallurgy | 1 | Expired |
| US6165459A | Methods for suppressing myeloid cells with chemokines | Chemistry; Metallurgy | 1 | Expired |
| US11883435B2 | Compositions and methods for treating a clinical condition through the use of hematopoietic stem cells | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.